Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034063 (
pulmonary edema
)
10,665
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Agonist-induced activation of Rho GTPase signaling leads to endothelial cell (EC) permeability and may culminate in
pulmonary edema
, a devastating complication of acute lung injury.
Cingulin
is an adaptor protein first discovered in epithelium and is involved in the organization of the tight junctions. This study investigated the role of
cingulin
in control of agonist-induced lung EC permeability via interaction with RhoA-specific activator GEF-H1. The siRNA-induced
cingulin
knockdown augmented thrombin-induced EC permeability monitored by measurements of transendothelial electrical resistance and endothelial cell permeability for macromolecules. Increased thrombin-induced permeability in ECs with depleted
cingulin
was associated with increased activation of GEF-H1 and RhoA detected in pulldown activation assays. Increased GEF-H1 association with
cingulin
was essential for down-regulation of thrombin-induced RhoA barrier disruptive signaling. Using
cingulin
-truncated mutants, we determined that GEF-H1 interaction with the rod + tail domain of
cingulin
was required for inactivation of GEF-H1 and endothelial cell barrier preservation. The results demonstrate the role for association of GEF-H1 with
cingulin
as the mechanism of RhoA pathway inactivation and rescue of EC barrier after agonist challenge.
...
PMID:Role of Cingulin in Agonist-induced Vascular Endothelial Permeability. 2759 Mar 42